Top 10 Pharmaceutical Stocks with Highest Return on Equity: SNTS, VRX, IPXL, GSK, ALXN, LLY, AZN, TRMS, NVO, QCOR (Jun 14, 2010)
"Strong Buy" Rated U.S.-Listed Chinese Stocks (February 8, 2012)
Below are the top 10 Pharmaceutical stocks with highest Return on Equity (ROE) ratio for the last 12 months. ROE shows a company's efficiency in making profits from shareholders' equity. It is equal to net profits divided by shareholders' equity.
Santarus, Inc. (NASDAQ:SNTS) has the 1st highest Return on Equity in this segment of the market. Its ROE was 109.09% for the last 12 months. Its net profit margin was 19.32% for the same period. Valeant Pharmaceuticals International (NYSE:VRX) has the 2nd highest Return on Equity in this segment of the market. Its ROE was 74.73% for the last 12 months. Its net profit margin was 29.67% for the same period. Impax Laboratories, Inc. (NASDAQ:IPXL) has the 3rd highest Return on Equity in this segment of the market. Its ROE was 68.43% for the last 12 months. Its net profit margin was 28.78% for the same period. GlaxoSmithKline plc (ADR) (NYSE:GSK) has the 4th highest Return on Equity in this segment of the market. Its ROE was 61.29% for the last 12 months. Its net profit margin was 20.36% for the same period. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has the 5th highest Return on Equity in this segment of the market. Its ROE was 59.30% for the last 12 months. Its net profit margin was 71.28% for the same period.
Eli Lilly & Co. (NYSE:LLY) has the 6th highest Return on Equity in this segment of the market. Its ROE was 46.90% for the last 12 months. Its net profit margin was 19.14% for the same period. AstraZeneca plc (ADR) (NYSE:AZN) has the 7th highest Return on Equity in this segment of the market. Its ROE was 45.15% for the last 12 months. Its net profit margin was 24.29% for the same period. Trimeris, Inc. (NASDAQ:TRMS) has the 8th highest Return on Equity in this segment of the market. Its ROE was 37.58% for the last 12 months. Its net profit margin was 80.59% for the same period. Novo Nordisk A/S (ADR) (NYSE:NVO) has the 9th highest Return on Equity in this segment of the market. Its ROE was 35.46% for the last 12 months. Its net profit margin was 21.80% for the same period. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) has the 10th highest Return on Equity in this segment of the market. Its ROE was 34.06% for the last 12 months. Its net profit margin was 29.37% for the same period.
